Sorry, you need to enable JavaScript to visit this website.
跳转到主要内容


Palbociclib – how a novel process development approach provides IP advantages

Palbociclib – how a novel process development approach provides IP advantages

This whitepaper outlines how Dr. Reddy's holistic development approach can help our API partners across geographies to provide patients early access to the generic alternative of Palbocicilb while gaining or maintaining competitive advantages.

Our team of process experts draw on their integrated understanding of IP, process development (API and formulation), and API manufacturing to ensure that by design the process is lean, free from potential genotoxic impurities and  scalable to manufacture for early market entries.

To continue on reading our latest whitepaer please fill the contact form below :

You can also explore our Palbocicilb API offering by clicking on the link below:

https://api.drreddys.com/product/palbociclib

请填写下面的联系表以查看白皮书

给我们发电子邮件: api@drreddys.com |   +91 40 49002253